SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-041395
Filing Date
2023-08-10
Accepted
2023-08-10 16:30:59
Documents
59
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q onct-20230630.htm   iXBRL 10-Q 2522010
2 EX-10.1 onct-ex10_1.htm EX-10.1 110570
3 EX-31.1 onct-ex31_1.htm EX-31.1 19354
4 EX-31.2 onct-ex31_2.htm EX-31.2 19337
5 EX-32.1 onct-ex32_1.htm EX-32.1 9586
6 EX-32.2 onct-ex32_2.htm EX-32.2 9740
  Complete submission text file 0000950170-23-041395.txt   9296320

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT onct-20230630_cal.xml EX-101.CAL 38978
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT onct-20230630_lab.xml EX-101.LAB 410293
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT onct-20230630.xsd EX-101.SCH 51276
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT onct-20230630_def.xml EX-101.DEF 165710
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT onct-20230630_pre.xml EX-101.PRE 286134
53 EXTRACTED XBRL INSTANCE DOCUMENT onct-20230630_htm.xml XML 1999350
Mailing Address 12230 EL CAMINO REAL SUITE 230 SAN DIEGO CA 92130
Business Address 12230 EL CAMINO REAL SUITE 230 SAN DIEGO CA 92130 (858) 434-1113
Oncternal Therapeutics, Inc. (Filer) CIK: 0001260990 (see all company filings)

IRS No.: 621715807 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-50549 | Film No.: 231160059
SIC: 2834 Pharmaceutical Preparations